Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene
- PMID: 17118990
- DOI: 10.1210/jc.2006-1873
Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene
Abstract
Context: The autoimmune polyendocrine syndrome type I (APS I) is a rare disease that previously was difficult to diagnose. Autoantibody screening as well as mutational analysis of the disease gene autoimmune regulator (AIRE) are important diagnostic tools for this life-threatening syndrome.
Objective: The objective of the study was to identify all patients with APS I in Norway and correlate their clinical features with their autoantibody profiles and mutations in the AIRE gene.
Patients: We identified 36 Norwegian patients from 24 families with APS I (20 males, 16 females) during a nationwide survey for patients with Addison's disease and polyendocrine syndromes, seven of them only after their death.
Research design and methods: Clinical data were collected from questionnaires and patient records. AIRE mutations were determined by DNA sequencing. Most autoantibodies were measured in RIAs against recombinant autoantigens, but anti-type I interferon (IFN) antibodies were titrated in ELISA or antiviral interferon neutralization assays.
Results: The prevalence of APS I in Norway was estimated to be about 1:90,000. Several patients exhibited a milder phenotype with few APS I disease components and onset only in late adolescent or adulthood. The others showed about the same distribution of disease components as reported in Finnish patients. Eleven different mutations were identified in the AIRE gene, six of these were novel, i.e. c.22C>T (p.Arg8Cys), c.290T>C (p.Leu97Pro), c.402delC (p.Ser135GlnfsX12), c.879 + 1G>A (p.IVS7 + 1G>A), c.1249dupC (p.Leu417ProfsX7), and c.1336T>G (p.Cys446Gly). The 13-bp deletion in exon 8 (c.967-979del13) was the most prevalent mutation, present in 23 of 48 (48%) of the alleles. The presence of neutralizing autoantibodies against IFN-omega was the most specific marker of APS I, being found in all but one Norwegian patient. Some other common APS I-associated autoantibodies appeared de novo during long-term follow-up of younger patients.
Conclusions: Norwegian patients with APS I clinically resemble those from Finland and other European countries, but some have milder phenotypes. In total, six new mutations were identified in the Norwegian APS I patients. Anti-type I IFN autoantibodies are easily detectable; their APS I specificity and persistently high titers render them reliable markers of APS I, even in prodromal or atypical cases. Both the clinical features and the AIRE mutations are more diverse in the Norwegian population than previously thought.
Similar articles
-
Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease.Eur J Endocrinol. 2008 May;158(5):705-9. doi: 10.1530/EJE-07-0843. Eur J Endocrinol. 2008. PMID: 18426830
-
Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.J Clin Endocrinol Metab. 2008 Nov;93(11):4389-97. doi: 10.1210/jc.2008-0935. Epub 2008 Aug 26. J Clin Endocrinol Metab. 2008. PMID: 18728167
-
Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.Clin Endocrinol (Oxf). 2001 Feb;54(2):211-7. doi: 10.1046/j.1365-2265.2001.01201.x. Clin Endocrinol (Oxf). 2001. PMID: 11207636
-
Update on autoimmune polyendocrine syndromes (APS).Acta Biomed. 2003 Apr;74(1):9-33. Acta Biomed. 2003. PMID: 12817789 Review.
-
Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.J Intern Med. 2009 May;265(5):514-29. doi: 10.1111/j.1365-2796.2009.02090.x. J Intern Med. 2009. PMID: 19382991 Review.
Cited by
-
An uncommon presentation of autoimmune polyglandular syndrome type 1 (APS-1)-A case report.Clin Case Rep. 2024 May 27;12(6):e9015. doi: 10.1002/ccr3.9015. eCollection 2024 Jun. Clin Case Rep. 2024. PMID: 38808199 Free PMC article.
-
Interferon autoantibodies as signals of a sick thymus.Front Immunol. 2024 Feb 22;15:1327784. doi: 10.3389/fimmu.2024.1327784. eCollection 2024. Front Immunol. 2024. PMID: 38455040 Free PMC article. Review.
-
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.Immunol Rev. 2024 Mar;322(1):98-112. doi: 10.1111/imr.13304. Epub 2024 Jan 9. Immunol Rev. 2024. PMID: 38193358 Review.
-
A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1.J Clin Invest. 2023 Nov 1;133(21):e169704. doi: 10.1172/JCI169704. J Clin Invest. 2023. PMID: 37909333 Free PMC article.
-
Molecular cloning, prokaryotic expression and its application potential evaluation of interferon (IFN)-ω of forest musk deer.Sci Rep. 2023 Jun 30;13(1):10625. doi: 10.1038/s41598-023-37437-x. Sci Rep. 2023. PMID: 37391585 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous